In ₹ Crore except Per Share Latest Annual | UNICHEMLAB FY26 | GUFICBIO FY26 | RPGLIFE FY26 | GUJTHEM FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 14.76× | 66.84× | 153.76× | — | 110.30× -87% | |
| P/B | ◆ 1.37× | 6.45× | 7.59× | 16.28× | 7.59× -82% | |
| EV/EBITDA | ◆ 21.23× | 30.48× | 29.80× | 64.11× | 30.48× -30% | |
| Market Cap | ₹3,731 Cr | ₹4,290 Cr | ₹4,597 Cr | ₹4,685 Cr | ₹4,597 Cr -19% | |
| Growth | ||||||
| Revenue CAGR 3Y | 17.91% | — | — | — | — | |
| Revenue CAGR 5Y | 12.26% | — | — | — | — | |
| Revenue YoY (latest Q) | 20.13% | 16.58% | — | ◆ 22.07% | 19.32% +4% | |
| Net Income YoY (latest Q) | ◆ 496.08% | 70.71% | — | 22.12% | 46.41% +969% | |
| Profitability | ||||||
| EBITDA Margin | 8.36% | 16.03% | 20.79% | ◆ 45.55% | 20.79% -60% | |
| Net Income Margin | 11.48% | 6.80% | 16.28% | ◆ 28.15% | 16.28% -29% | |
| Return on Common Equity | 9.30% | 9.66% | ◆ 19.02% | 16.22% | 16.22% -43% | |
| Return on Capital Employed | 2.07% | 14.61% | ◆ 19.86% | 14.76% | 14.76% -86% | |
| Return on Assets | 6.77% | 4.78% | ◆ 14.52% | 9.27% | 9.27% -27% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.17× | 0.58× | ◆ 0.03× | 0.56× | 0.56× -70% | |
| Interest Coverage | 1.87× | 3.29× | ◆ 141.13× | 21.23× | 21.23× -91% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,202 Cr | ₹944 Cr | ₹708 Cr | ₹166 Cr | ₹708 Cr +211% | |
| Net Income | ₹253 Cr | ₹64.2 Cr | ₹115 Cr | ₹46.7 Cr | ₹64.2 Cr +294% | |
| Total Assets | ₹3,737 Cr | ₹1,342 Cr | ₹793 Cr | ₹503 Cr | ₹793 Cr +371% | |
| EPS | ₹35.91 | ₹6.4 | ₹18.08 | ₹0 | ₹6.4 +461% | |
| Book Value per Share | ₹386 | ₹66.31 | ₹366.07 | ₹26.41 | ₹66.31 +482% | |